Development of eftx-001 to target kras mutations in cancer
Ended Project Grant Awarded Last action
- Award ID
- R41CA246848
- Recipient
-
Enfuego Therapeutics, Inc. UEI N4XYELPNM224
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,995
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,995 |
Quick answers
Who received award R41CA246848?
R41CA246848 was awarded to Enfuego Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on June 1, 2020.
How much is award R41CA246848 worth?
$224,995 has been obligated on R41CA246848.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award